Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | President and COO | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,617 |
Reported balance
After 2026-08-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-20 · Tax withholding · Disposed 714 · Balance 39,617 F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2: Includes 24,402 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 2,512 shares will vest on November 20, 2026, 2,520 shares vest on March 6, 2027, 2,200 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,204 shares vest on March 6, 2028, 1,694 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,716 shares will vest on March 6, 2029, 936 shares vest on each of May 20, 2029, August 20, 2029 and November 20, 2029, and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
F2: Includes 24,402 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 2,512 shares will vest on November 20, 2026, 2,520 shares vest on March 6, 2027, 2,200 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,204 shares vest on March 6, 2028, 1,694 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,716 shares will vest on March 6, 2029, 936 shares vest on each of May 20, 2029, August 20, 2029 and November 20, 2029, and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 23:12 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Tax withholdingCommon Stock | 714 | $78.00 | $55,692.00 |
DisclosureSEC source: 0001193125-26-363896 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,617 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 24,402 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 2,512 shares will vest on November 20, 2026, 2,520 shares vest on March 6, 2027, 2,200 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,204 shares vest on March 6, 2028, 1,694 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,716 shares will vest on March 6, 2029, 936 shares vest on each of May 20, 2029, August 20, 2029 and November 20, 2029, and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:45 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072715 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,331 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in fifteen (15) equal quarterly installments of 936 shares vesting on each of May 20, August 20, November 20, and March 6 of each of the years 2026, 2027, 2028, and 2029. The final 960 shares vesting on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. F2 · balance_after: Includes 31,322 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,896 shares vest on March 6, 2026; 2,512 shares vest on May 20, 2026, August 20, 2026, November 20, 2026; 2,520 shares vest on March 6, 2027; 2,200 shares vest on May 20, 2027, August 20, 2027, and November 20, 2027; 2,204 shares vest on March 6, 2028; 1,694 shares vest on May 20, 2028, August 20, 2028, and November 20, 2028; 1,716 shares will vest on March 6, 2029; 936 shares vest on May 20, 2029, August 20, 2029 and November 20, 2029; and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $85.25 | $85,250.00 |
DisclosureSEC source: 0000950170-25-113554 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,331 F1 · balance_after: Includes 18,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026,1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares on each of May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 633 | $78.09 | $49,430.97 |
DisclosureSEC source: 0000950170-25-076378 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,331 F1 · price: The price reported $78.09 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 20,382 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 2,172 shares on each of August 20, 2025, 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026, 1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares of each on May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 01:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 12,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028169 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,964 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 756 shares vesting on each of May 20, August 20, November 20 and March 6 in each year 2025, 2026, 2027 and 2028, with the final 780 shares vesting on March 6, 2029, if he is employed by the Company on those dates. F2 · balance_after: Includes the shares noted in footnote 1 and 10,398, shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 10,398, 1,408 will vest on May 20, 2025, 1,414 will vest on August 20, 2025, 1,130 will vest on November 20, 2025, 1,138 will vest on March 6, 2026, 818 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 826 will vest on March 6, 2027, 506 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 510 will vest on March 6, 2028, if he is employed on those dates. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $95.84 | $191,680.00 |
DisclosureSEC source: 0000950170-24-125738 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,814 F1 · price: The price reported ($95.84)is weighted average price. The shares were sold in multiple transactions at prices ranging from $95.83 to $95.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 11,806 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,409 shares on January 1, 2025; 1,408 shares on April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:19 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,500 | $104.22 | $260,550.00 |
DisclosureSEC source: 0000950170-24-059855 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,814 F1 · price: The price reported ($104.22) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $104.00 to $105.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 14,622 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,408 shares on each of July 1, 2024 and October 1, 2024; 1,409 shares on January 1, 2025; 1,408 shares on April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $105.14 | $105,140.00 |
DisclosureSEC source: 0000950170-24-026469 · ownership.xml · nonDerivative · entry 2 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,314 F1 · balance_after: Includes 16,030 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,408 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,409 shares on January 1, 2025; 1,408 shares on April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 500 | $104.60 | $52,300.00 |
DisclosureSEC source: 0000950170-24-026469 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,314 Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 01:23 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022518 · ownership.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,814 F1 · shares: The 8,100 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 506 shares vesting on April 1, 2024 thereafter 506 shares on April 1, July 1, October 1 and January 1 of each year with the final 510 shares lapsong on Janaury 1, 2028 if he is employed by the Company on those dates. F2 · balance_after: Includes 16,030 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,408 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,409 shares on January 1, 2025; 1,408 shares on each of April 1, 2025, 1,414 shares on July 1, 2025, 1,130 on October 1, 2025; 1,139 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 650 | $101.70 | $66,105.00 |
DisclosureSEC source: 0001209191-23-016291 · doc4.xml · nonDerivative · entry 2 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,714 F1 · balance_after: Includes 9,036 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 624 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, January 1, 2024, April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025; 908 shares on July 1, 2025; 624 shares on October 1, 2025; 632 shares on January 1, 2026; and 312 shares on April 1, 2026, July 1, 2026 and October 1, 2026 and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 500 | $101.60 | $50,800.00 |
DisclosureSEC source: 0001209191-23-016291 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,364 F1 · balance_after: Includes 9,036 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 624 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, January 1, 2024, April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025; 908 shares on July 1, 2025; 624 shares on October 1, 2025; 632 shares on January 1, 2026; and 312 shares on April 1, 2026, July 1, 2026 and October 1, 2026 and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 22:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012323 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,864 F1 · shares: The 5,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments with 312 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 320 shares vesting on January 1, 2027, if he is employed by the Company on those dates. F2 · balance_after: Includes 9,036 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 624 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, January 1, 2024, April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025; 908 shares on July 1, 2025; 624 shares on October 1, 2025; 632 shares on January 1, 2026; and 312 shares on April 1, 2026, July 1, 2026 and October 1, 2026 and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 590 | $86.04 | $50,763.60 |
DisclosureSEC source: 0001209191-22-056117 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,864 F1 · balance_after: Includes 7,128 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 590 shares on each of January 1, April 1, July 1 and October 1, 2023, and on each of January 1, April 1, July 1 and October 1, 2024, and on each of January 1 and April 1, 2025; 596 shares on July 1, 2025; 312 shares on October 1, 2025; and 320 shares on January 1, 2026, if he is an employee of the Company on those dates. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 16:19 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 500 | $93.15 | $46,575.00 |
DisclosureSEC source: 0001209191-22-019101 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,454 F1 · price: Includes the 8,898 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 590 shares on April 1, 2022 and thereafter on January 1, April 1, July 1 and October 1 of each year through April 1, 2025 with the final 1,228 shares restrictions lapsing as follows: 596 shares on July 1, 2025, 312 shares on October 1, 2025, and 320 shares on January 1, 2026. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 14:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018695 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,954 F1 · shares: The 5,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 312 shares on April 1, 2022 and thereafter with 312 shares on April 1, July 1, October 1 and January 1 of each year with the final 320 shares lapsing on January 1, 2026, if he is employed by the Company on those dates. F2 · balance_after: Includes the 5,000 shares in Footnote 1 and includes 3,898 shares which restrictions lapse as to 278 shares on April 1, 2022 and thereafter on January 1, April 1, July 1 and October 1 of each year with the final 284 shares restrictions lapsing on July 1, 2025. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:58 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 4,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052422 · doc4.xml · nonDerivative · entry 1 Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,954 F1 · shares: The 4,454 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 278 shares on October 1, 2021 and thereafter with 278 shares on January 1, April 1 and October 1 of each year with the final 284 shares lapsing on July 1, 2025, if he is employed by the Company on those dates. F2 · balance_after: Includes the 4,454 shares of common stock that was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan detailed in Footnote 1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.